Search results for: Adrian Towse
Filter search results
The State of Play for Cost-effectiveness Thresholds
28 June 2022
…Sampson, C., Zamora, B., Watson, S., Cairns, J., Chalkidou, K., Cubi-Molla, P., Devlin, N., García-Lorenzo, B., Hughes, D.A., Leech, A.A. and Towse, A., 2022. Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based…
It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?
1 December 2021
…cost-effective treatments for patients, with the innovator getting revenues, and the payer having confidence that it is not wasting money. Please cite this report as Towse, A. and Fenwick, E.,…
The Ideas and Influence of Alan Williams: Be Reasonable – Do It My Way
1 February 2008
Share this: Download publication Anne R. Mason Adrian Towse A tribute to our friend and colleague, Alan Williams. Share this: Download publication The sign on Alan Williams’ desk revealed his…
Financing Health Care in the UK: A Discussion of NERA’s Prototype Model to Replace the NHS
1 January 1995
Share this: Download publication Adrian Towse There is little doubt that throughout the world there is a growing concern about health services and the provision of health care. It is…
Value of the Pharmaceutical Industry to the UK Economy
1 June 1995
Share this: Download publication David Hale Adrian Towse Although there is widespread agreement about the important role the pharmaceutical industry plays in the U K economy, there is no easily…
Guidelines for the Economic Evaluation of Pharmaceuticals: Can the UK learn from Australia and Canada?
1 May 1997
Share this: Download publication Adrian Towse Getting value for money from the use of pharmaceuticals is crucial for the NHS. This publication explores the role for guidelines in generating good…
Regulating Prices Paid by the NHS for Medicines Supplied by the UK-Based Pharmaceutical Industry
1 October 1997
Share this: Download publication Martin Cave Adrian Towse The aim of this paper is to review alternative methods of regulating the price of pharmaceuticals bought by the NHS from the…
Disease Management, the NHS and the Pharmaceutical Industry
1 March 1999
Share this: Download publication Anne R. Mason Michael F. Drummond Adrian Towse Disease management is a term with multiple and ambiguous meanings. For some, it is purely a form of…
Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?
1 June 2022
Share this: Download publication Sian Hodgson Nadine Henderson Adrian Towse Amanda Cole Gene therapies represent a new era of medicine, offering the potential for truly transformational health gains, and further…